(Q37995965)

26 August 2017

title

Tuberous sclerosis and epilepsy: role of astrocytes (English)

1 reference

26 August 2017

0 references

1 reference

Michael Wong

1

1 reference

26 August 2017

Peter B Crino

series ordinal

2

1 reference

26 August 2017

publication date

21 March 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

60

1 reference

26 August 2017

issue

8

1 reference

26 August 2017

page(s)

1244-1250

1 reference

Loss of the TSC2 product tuberin in subependymal giant-cell tumors.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

The natural history of epilepsy in tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

The tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Embryonic neuronal markers in tuberous sclerosis: single-cell molecular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

The natural history and treatment of epilepsy in a murine model of tuberous sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Subependymal giant cell tumors in tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Epileptogenesis and reduced inward rectifier potassium current in tuberous sclerosis complex-1-deficient astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Different transcription factors regulate nestin gene expression during P19 cell neural differentiation and central nervous system development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Biological behavior and tumorigenesis of subependymal giant cell astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Immunohistochemical characterization of subependymal giant cell astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Surgical outcome in tuberous sclerosis complex: a multicenter survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Expression patterns of glial fibrillary acidic protein (GFAP)-delta in epilepsy-associated lesional pathologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Early progenitor cell marker expression distinguishes type II from type I focal cortical dysplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Enhanced epidermal growth factor, hepatocyte growth factor, and vascular endothelial growth factor expression in tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Astrocyte dysfunction in epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Abnormal cortical cells and astrocytomas in the Eker rat model of tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Solitary subependymal giant cell astrocytoma incidentally found at autopsy in an elderly woman without tuberous sclerosis complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Novel proteins regulated by mTOR in subependymal giant cell astrocytomas of patients with tuberous sclerosis complex and new therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Morphology of cerebral lesions in the Eker rat model of tuberous sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Impaired astrocytic gap junction coupling and potassium buffering in a mouse model of tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Giant cells in cortical tubers in tuberous sclerosis showing synaptophysin-immunoreactive halos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Tsc1 mutant neural stem/progenitor cells exhibit migration deficits and give rise to subependymal lesions in the lateral ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

7 January 2021

Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

7 January 2021

Are cortical tubers epileptogenic? Evidence from electrocorticography

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

7 January 2021

Expression of ICAM-1, TNF-alpha, NF kappa B, and MAP kinase in tubers of the tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

7 January 2021

Tuberous sclerosis: a primary pathology of astrocytes?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22326

7 January 2021

Identifiers

DOI

10.1002/GLIA.22326

1 reference

26 August 2017

1 reference